|Bid||2.4300 x 1800|
|Ask||2.4600 x 1800|
|Day's Range||2.4300 - 2.4600|
|52 Week Range||2.0000 - 3.3300|
|Beta (3Y Monthly)||1.05|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 13, 2019 - Mar 15, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.00|
The big shareholder groups in Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies...
On a per-share basis, the Vancouver, British Columbia-based company said it had a loss of 64 cents. The company's shares closed at $2.48. A year ago, they were trading at $11.40. _____ This story was generated ...
VANCOUVER, British Columbia, Nov. 07, 2018 -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a pharmaceutical company discovering and developing novel drug candidates.
NEW YORK, Nov. 01, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
On a per-share basis, the Vancouver, British Columbia-based company said it had net income of 12 cents. The drugmaker posted revenue of $25 million in the period. The company's shares closed at $3.07. ...
HENDERSON NV / ACCESSWIRE / July 24, 2018 / BioRestorative Therapies, Inc. (BRTX) is a small stem cell company, that has came across our radar screen. Just a few years ago BRTX was trading as high as $10 plus per share, and a high of $3.75 this year alone. Over the last few weeks interest in BRTX has been climbing, and the company has done higher volume days recently than ever before in BRTX trading history.
Stock Research Monitor: PRGO, RHE, and AMRX LONDON, UK / ACCESSWIRE / July 24, 2018 / If you want a free Stock Review on AQXP sign up now at www.wallstequities.com/registration . On Monday, July 23, 2018, ...